ADVFN Logo ADVFN

No pudimos encontrar ningún resultado para:
Asegúrate de que la ortografía sea correcta o intenta ampliar tu búsqueda.

Tendencias Ahora

Listas Principales

Parece que no has iniciado sesión.
Haz clic en el botón de abajo para iniciar sesión y ver tu historial reciente.

Regístrate

¿Ya eres miembro? Iniciar sesión

Los Principales Corredores en Línea

Más Corredores en Línea

Datos
Noticias
Herramientas
Mercados
Descubrir

Hot Features

Follow Feed

Conéctese con traders e inversores en nuestra comunidad Follow Feed.

Flujo de Opciones

Explora datos de opciones completos y utiliza filtros avanzados con Options Flow.

Monitor

Organiza y monitorea tu lista de seguimiento de acciones y activos con Monitor.
Iniciar Sesión Premium IconPremium Help Menu
S&P 500
5,942.47
1.26%
Dow Jones
42,732.13
0.80%
US Dollar vs MXN
20.6314
0.00%
Brent Oil
76.495
0.00%
Bitcoin
98,259.91
0.05%
Pepperstone
Advertisement
Registration Strip Icon for default Regístrate gratis para obtener cotizaciones en tiempo real, gráficos interactivos, flujo de opciones en vivo y más.
Regístrate
  1. Inicio
  2. Invertir
  3. Acciones
  4. Reino Unido
  5. LSE

  6. Boozt Ab (0RPY) Cotización

Boozt Ab

Boozt Ab (0RPY)

LSE
39.725
0.00
(0.00%)
Cerrado 05 Enero 10:30AM
Delayed by 15 minutes

Herramientas de nivel profesional para inversores individuales.

Premium

Estadísticas y detalles clave

Último Precio
39.725
Postura de Compra
38.75
Postura de Venta
40.70
Volume Operado de la Acción
1,290
0.00 Rango del Día 0.00
39.725 Rango de 52 semanas 39.725
Capitalización de Mercado [m]
2.713B
Precio Anterior
39.725
Precio de Apertura
-
Hora
94
@
128.4
(O)
Última hora de negociación
Volumen financiero
-
Precio Promedio Ponderado
-
Volumen promedio (3 m)
12,397
Acciones en circulación
68,289,000
Rendimiento del Dividendo
-
Ratio Precio/Utilidad
11.64
Beneficio por acción (BPA)
3.41
turnover
7.76B
Beneficio neto
233M

Acerca de Boozt Ab

Sector
Apparel & Accessories, Nec
Industria
Apparel & Accessories, Nec
Sitio web
www.booztfashion.com
Sede
Malmo, Swe
Fundado
-
Boozt Ab is listed in the Apparel & Accessories sector of the London Stock Exchange with ticker 0RPY. The last closing price for Boozt Ab was SEK39.73. Over the last year, Boozt Ab shares have traded in a share price range of SEK 39.725 to SEK 39.725.

Boozt Ab currently has 68,289,000 shares in issue. The market capitalisation of Boozt Ab is SEK2.71 billion. Boozt Ab has a price to earnings ratio (PE ratio) of 11.64.

0RPY Últimas noticias

Más noticias
No news to show yet.
Período †Variación(Ptos)Variación %AperturaPrecio MáximoPrecio MínimoAvg. Vol. diarioPrecio Promedio Ponderado
10039.72539.72539.725122439.725DE
40039.72539.72539.725113539.725DE
120039.72539.72539.7251239739.725DE
260039.72539.72539.725986739.725DE
520039.72539.72539.725994839.725DE
1560039.72539.72539.7251601839.725DE
260-13.575-25.46904315253.356.635.3751789939.79089774DE

0RPY - Preguntas Frecuentes

¿Cuál es el precio actual de las acciones de Boozt Ab?
El precio actual de las acciones de Boozt Ab es SEK 39.725
¿Cuántas acciones de Boozt Ab están en circulación?
Boozt Ab tiene 68,289,000 acciones en circulación
¿Cuál es la capitalización de mercado de Boozt Ab?
La capitalización de mercado de Boozt Ab es SEK 2.71B
¿Cuál es el rango de negociación de 1 año para el precio de las acciones de Boozt Ab?
Boozt Ab ha negociado en un rango de SEK 39.725 a SEK 39.725 durante el último año
¿Cuál es el ratio PE (precio/beneficio) de Boozt Ab?
El ratio precio/beneficio de Boozt Ab es 11.64
¿Cuál es el ratio de efectivo a ventas de Boozt Ab?
El ratio de efectivo a ventas de Boozt Ab es 0.35
¿Cuál es la moneda de reporte de Boozt Ab?
Boozt Ab presenta sus resultados financieros en SEK
¿Cuál es el último ingresos anual de Boozt Ab?
El último ingresos anual de Boozt Ab es SEK 7.76B
¿Cuál es el último beneficio anual de Boozt Ab?
El último beneficio anual de Boozt Ab es SEK 233M
¿Cuál es la dirección registrada de Boozt Ab?
La dirección registrada de Boozt Ab es HYLLIE BOULEVARD 10 B, MALMO, SE-215 32
¿Cuál es la dirección del sitio web de Boozt Ab?
La dirección del sitio web de Boozt Ab es www.booztfashion.com
¿En qué sector industrial opera Boozt Ab?
Boozt Ab opera en el sector APPAREL & ACCESSORIES, NEC

Movimientos

Ver todo
  • Volumen
  • % Mayores Alzas
  • % Mayores Bajas
SímboloPrecioVol.
TCFTheracryf Plc
0.725p
(38.10%)
7.56M
NMTNeometals Ltd
3.50p
(27.27%)
346.81k
SCHOScholium Group Plc
44.00p
(25.71%)
30.65k
FABFusion Antibodies Plc
10.15p
(24.54%)
3.34M
PYXPyx Resources Limited
3.49p
(22.24%)
8.43k
TM1Technology Minerals Plc
0.125p
(-24.24%)
37.21M
QUIZQuiz Plc
0.70p
(-18.60%)
3.67M
SYMESupply@me Capital Plc
0.003p
(-17.81%)
168.35M
OBDOxford Biodynamics Plc
1.20p
(-14.29%)
827.83k
ZENZenith Energy Ltd.
5.25p
(-13.93%)
5.39M
TRPTower Resources Plc
0.0395p
(5.33%)
539.51M
CPXCap-xx Limited
0.1825p
(1.39%)
494M
NTVONativo Resources Plc
0.0019p
(0.00%)
320.16M
DGIDg Innovate Plc
0.0225p
(-13.46%)
208.21M
ENETEthernity Networks Ltd
0.1125p
(2.27%)
207.56M

Discusión

Ver feed completo
DonVance DonVance 2 minutos hace
This will hit 1k this year I believe now.
MSTR
georgejjl georgejjl 3 minutos hace
How many of the 7 million Alzheimer’s patients in the USA are projected to be treated with the MAB infusions during 2025???

How many people with Alzheimer’s in the USA are projected to be treated with donepezil (Aricept) or memantine during 2025???

The treatment used t
AVXL
Mr. Bill Mr. Bill 3 minutos hace
Stretches https://www.healthline.com/health/back-pain/sciatic-stretches#sitting-spinal-stretch
Graniteguy Graniteguy 4 minutos hace
Doc and Investor posters here tend to be negatively biased which you whole heartedly champion, especially "Doc" who's medical opinion is at best questionable, and incredibly biased, to fit a narrative of constant failure for Anavex's Blarcamesine. The fact that you pile onto their "steaming pile of
AVXL
BDEZ BDEZ 6 minutos hace
The Russes hit the jackpot?
BDEZ BDEZ 7 minutos hace
40% of homicides in the US take place in districts with a Soros-funded prosecutor.

Biden gave him a Medal Of Freedom.

https://x.com/EndWokeness/status/1875725808071012529
BDEZ BDEZ 8 minutos hace
Not good, thanks for sharing.
sand sand 15 minutos hace
Thank you Ducci for all your sharing and insights extremely helpful. I'm slowly diligently getting there rewiring the brain and focusing on what shows the moves. Much continued success this week. Thank you again.
SPY
mining101 mining101 15 minutos hace
Moving hard soon 
EFSH
mining101 mining101 17 minutos hace
Superb
MEGL
benz280c benz280c 24 minutos hace
Speak louder and maybe you will convince somebody that this is how you really feel. No need to be insecure around your fellow investors.
GDVM
rx7171 rx7171 30 minutos hace
In addition MABs are approved for only a limited portion of the AD population, whereas Blarcamasine appears to be effective in 70-80% of the ITT population with its strongest efficacy in the 70% with wild type Sigma-1.
AVXL
TheHound TheHound 31 minutos hace
Learn how to use the bull market support band with that chart and you’ll have a powerful tool under your belt!
XRPUSD
Investor2014 Investor2014 34 minutos hace
When I say that the totality of information is what Anavex rely on it does take into account the pretty ineffective SOC, associated risks and inconveniences for patients.

Still any drug regulatory process must and should look carefully at the data to ensure that neither type one or tw
AVXL
nowwhat2 nowwhat2 40 minutos hace
Just learnt of the Total 3 today.......Appears to be a good thing to have learnt of.

3 month
https://investorshub.advfn.com/uimage/uploads/2025/1/5/siwcoTOTAL_3_!_4_3M_JUNCT_DAY_1.jpg



Because how the overall mkt resolves itself is gonna'r have con
BTCUSD
rx7171 rx7171 40 minutos hace
Yes that spike to $23 in June of 2021 was driven entirely by the excellent Phase II data for PDD.

Yet now after completing the AD 2b/3 trial and having an EMA MAA accepted for evaluation the share price is barely half that number!

I understand the company being very ca
PDD
sunspotter sunspotter 45 minutos hace
Black Cat Moan was one of my favorites back in the day:

https://youtu.be/cxN-frB1UbI?si=Ph6XMC3omR0rRlmR

Edit: auto correct changed Moan to Moana. The cultural prevalence of Disney.
Investor2014 Investor2014 47 minutos hace
The ex-biotech executive is back in the Rett trap posting mode - hope it goes better with the biased approach this time.

Listing all the site PI’s is not world class peer review WGT confirmation.
AVXL
nowwhat2 nowwhat2 48 minutos hace
Just learnt of the Total 3 today.......Appears to be a good thing to have learnt of.

3 month
https://investorshub.advfn.com/uimage/uploads/2025/1/5/siwcoTOTAL_3_!_4_3M_JUNCT_DAY_1.jpg



Because how the overall mkt resolves itself is gonna'r have con
sunspotter sunspotter 51 minutos hace
I rather think you missed the point. It’s not that higher doses of GALT’s drug are toxic, it’s that they are ineffective.

Given the purported mechanism, that almost certainly means lower doses are too, and that the implication that the lower dose worked is merely an artefact.
GALT
nowwhat2 nowwhat2 53 minutos hace
Just learnt of the Total 3 today.......Appears to be a good thing to have learnt of.

3 month
https://investorshub.advfn.com/uimage/uploads/2025/1/5/siwcoTOTAL_3_!_4_3M_JUNCT_DAY_1.jpg



Because how the overall mkt resolves itself is gonna'r have con
XRPUSD
CrossFireTrader CrossFireTrader 56 minutos hace
I try to avoid Krispy Kreme's af all costs. Thanks for your insight...
GDVM
skitahoe skitahoe 57 minutos hace
Dstock, you may be very right about the data from compassionate use being included, but if it is, I would think that the protocols used on every one of those patients would need to be included as none are specifically on the trial protocol. It's essentially anecdotal evidence, but it could all add
NWBO

Su Consulta Reciente

LSE
0RPY
Boozt Ab
Delayed Upgrade Clock
ADVFN Logo
InvestorsHub

México
Empresa
Negocios
Popular
Obtener la aplicación
App Store
Google Play

Soporte: (55) 4170 8128 | soporte@advfn.mx

Al acceder a los servicios disponibles de ADVFN usted acepta quedar sujerto a los Términos y Condiciones

© 2025 ADVFN PLC - Todos los derechos reservados